X4 Pharmaceuticals secures $150M debt facility with K2 HealthVentures

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. REGN
2. LITE
3. CRWD
4. AAPL
5. ABBV
6. MRVL
7. CL
8. TFII
9. ORCL
10. LYB

Go back to X4 Pharmaceuticals secures $150M debt facility with K2 HealthVentures

X4 Pharmaceuticals Secures Up to $150 Million Senior Debt Facility with K2 HealthVentures

October 8, 2026 7:00 AM EDT

- Repayment of Existing Loan Facility Completed -

- Strengthens Financial Flexibility with Access to Funding for Corporate and Commercial Activities -

- Expect Completion of Enrollment in Phase 3 4WARD trial by Year-End 2026 and Topline Data in H1 2028 -

BOSTON, Oct. 08, 2026 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company focused on improving the lives of people with rare hematology diseases, today announced that it has entered into a senior secured term loan facility of up to $150 million with K2 HealthVentures LLC (K2HV), an... More